Bank of New York Mellon’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $624K | Buy |
298,598
+109,201
| +58% | +$228K | ﹤0.01% | 3369 |
|
|
2025
Q1 | $323K | Sell |
189,397
-2,983
| -2% | -$5.09K | ﹤0.01% | 3649 |
|
|
2024
Q4 | $972K | Sell |
192,380
-1,834
| -0.9% | -$9.26K | ﹤0.01% | 3165 |
|
|
2024
Q3 | $1.06M | Sell |
194,214
-59,799
| -24% | -$325K | ﹤0.01% | 3103 |
|
|
2024
Q2 | $1.22M | Buy |
254,013
+97,931
| +63% | +$470K | ﹤0.01% | 3075 |
|
|
2024
Q1 | $485K | Sell |
156,082
-20,270
| -11% | -$63K | ﹤0.01% | 3532 |
|
|
2023
Q4 | $501K | Sell |
176,352
-88,056
| -33% | -$250K | ﹤0.01% | 3544 |
|
|
2023
Q3 | $775K | Buy |
264,408
+3,302
| +1% | +$9.68K | ﹤0.01% | 3314 |
|
|
2023
Q2 | $747K | Sell |
261,106
-1,069
| -0.4% | -$3.06K | ﹤0.01% | 3373 |
|
|
2023
Q1 | $810K | Sell |
262,175
-5,532
| -2% | -$17.1K | ﹤0.01% | 3226 |
|
|
2022
Q4 | $565K | Buy |
267,707
+197,931
| +284% | +$418K | ﹤0.01% | 3481 |
|
|
2022
Q3 | $227K | Buy |
69,776
+13,536
| +24% | +$44K | ﹤0.01% | 3962 |
|
|
2022
Q2 | $180K | Buy |
56,240
+29,598
| +111% | +$94.7K | ﹤0.01% | 4094 |
|
|
2022
Q1 | $188K | Buy |
+26,642
| New | +$188K | ﹤0.01% | 4264 |
|